Old Dominion Capital Management »

Crispr Therapeutics shares owned by Old Dominion Capital Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Old Dominion Capital Management from 13F filings

Historical chart of Old Dominion Capital Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Old Dominion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Old Dominion Capital Management

Quarter filed Position value Share count Share price at filing
2021-09-30 $207k 1.9k 111.89
2021-06-30 $299k 1.9k 161.62
2021-03-31 $225k 1.9k 121.62
2020-12-31 $283k 1.9k 152.97

More positions owned by Old Dominion Capital Management

Vanguard Short-term Government Bond Etf Etf (VGSH)
Intuit Stock (INTU)
Vanguard Total Stock Market Index Fund Etf (VTI)
Schwab International Equity Etf Etf (SCHF)
Schwab U.s. Mid-cap Etf Etf (SCHM)
Adobe Systems Incorporated Stock (ADBE)
Spdr S&p 600 Small Cap Etf Etf
Texas Instrs Stock (TXN)
Ishares Floating Rate Bond Etf Etf (FLOT)
Cme Group Stock (CME)
Invesco Preferred Etf Etf (PGX)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Costco Whsl Corp Stock (COST)
Utilities Select Sector Spdr Fund Etf (XLU)
Spdr Portfolio S&p 500 Etf Etf (SPLG)

View all positions for Old Dominion Capital Management

Top funds holding Crispr Therapeutics

ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
NEA Management Company
Citadel Advisors
EcoR1 Capital
Susquehanna International
Morgan Stanley
Bank of America Corporation
Loomis, Sayles and
Dimensional Fund Advisors

View all funds holding Crispr Therapeutics